Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;7(5):1497-1498.
doi: 10.3892/ol.2014.1921. Epub 2014 Feb 27.

Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report

Pei-Hung Chang  1 , Mei-Ti Wang  2 , Yi-Hua Chen  2 , Yu-Ying Chen  2 , Cheng-Hsu Wang  3
Affiliations

Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report

Pei-Hung Chang et al. Oncol Lett. 2014 May.

Abstract

Chemotherapeutic agents can result in extravasation, which is considered to be a serious complication. The increasing number of exposures to different cytotoxic agents experienced by each patient may enhance the prevalence of this complication. Docetaxel is widely used in the treatment of numerous solid tumors. Thus, the current report presents the case of a breast cancer patient who developed a significantly delayed skin reaction one day after docetaxel extravasation, a rare skin manifestation, and relapsed one week subsequently. This unusual clinical presentation is an indicator that practitioners are required to carefully monitor the patient for further cutaneous reactions in the weeks following extravasation to observe any additional adverse reactions.

Keywords: chemotherapy; docetaxel; extravasation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Marked swelling, erythema and pruritis involving the left chest wall one day after docetaxel extravasation.
Figure 2
Figure 2
Erythema relapsed one week after docetaxel extravasation.
See this image and copyright information in PMC

References

    1. Bronner AK, Hood AF. Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol. 1983;9:645–663. - PubMed
    1. Albanell J, Baselga J. Systemic therapy emergencies. Semin Oncol. 2000;27:347–361. - PubMed
    1. Raley J, Geisler JP, Buekers TE, Sorosky JI. Docetaxel extravasation causing significant delayed tissue injury. Gynecol Oncol. 2000;78:259–260. - PubMed
    1. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol. 2004;15:858–862. - PubMed
    1. Ho CH, Yang CH, Chu CY. Vesicant-type reaction due to docetaxel extravasation. Acta Derm Venereol. 2003;83:467–468. - PubMed

LinkOut - more resources